Literature DB >> 16088108

Matrix metalloproteinases in cerebrovascular diseases.

Marc Fatar1, Mark Stroick, Martin Griebe, Michael Hennerici.   

Abstract

Matrix metalloproteinases are important factors for tissue remodelling and are activated during several physiological and pathological conditions, including cerebrovascular diseases. We give an overview of the structure, production and physiological effects of these widely distributed proteases and describe the genetic background and regulation pathways. In particular, we discuss the role of matrix metalloproteinases in vascular remodelling concerning ischaemic stroke, brain haemorrhage, vascular dementia, carotid artery plaques and cerebral aneurysms. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16088108     DOI： 10.1159/000087197

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN： 1015-9770            Impact factor:   2.762


  16 in total

Review 1.  Matrix metalloproteases: underutilized targets for drug delivery.

Authors:  Deepali G Vartak; Richard A Gemeinhart
Journal:  J Drug Target       Date:  2007-01       Impact factor: 5.121

2.  Original Research: The expression of MMP2 and MMP9 in the hippocampus and cerebral cortex of newborn mice under maternal lead exposure.

Authors:  Ning Li; Xing Li; Li Li; Pingan Zhang; Mingwu Qiao; Qiuyan Zhao; Lianjun Song; Zengli Yu
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-02

3.  AP-1 (Fra-1/c-Jun)-mediated induction of expression of matrix metalloproteinase-2 is required for 15S-hydroxyeicosatetraenoic acid-induced angiogenesis.

Authors:  Nikhlesh K Singh; Dong Van Quyen; Venkatesh Kundumani-Sridharan; Peter C Brooks; Gadiparthi N Rao
Journal:  J Biol Chem       Date:  2010-03-29       Impact factor: 5.157

4.  Effect of simvastatin on MMPs and TIMPs in human brain endothelial cells and experimental stroke.

Authors:  Björn Reuter; Claus Rodemer; Saskia Grudzenski; Stephen Meairs; Peter Bugert; Michael G Hennerici; Marc Fatar
Journal:  Transl Stroke Res       Date:  2014-12-05       Impact factor: 6.829

5.  Amelioration of inflammation and cytotoxicity by dipyridamole in brain endothelial cells.

Authors:  Shuzhen Guo; Monique Stins; MingMing Ning; Eng H Lo
Journal:  Cerebrovasc Dis       Date:  2010-07-23       Impact factor: 2.762

6.  Moderate and severe traumatic brain injury induce early overexpression of systemic and brain gelatinases.

Authors:  Anna Vilalta; Juan Sahuquillo; Anna Rosell; Maria A Poca; Marilyn Riveiro; Joan Montaner
Journal:  Intensive Care Med       Date:  2008-03-19       Impact factor: 17.440

Review 7.  Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature.

Authors:  A K Chow; J Cena; R Schulz
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

8.  Single nucleotide polymorphisms in monocyte chemoattractant protein-1 and its receptor act synergistically to increase the risk of carotid atherosclerosis.

Authors:  Paul A Nyquist; Cherie A Winkler; Louise M McKenzie; Lisa R Yanek; Lewis C Becker; Diane M Becker
Journal:  Cerebrovasc Dis       Date:  2009-06-05       Impact factor: 2.762

9.  Different roles of matrix metalloproteinases-2 and -9 after human ischaemic stroke.

Authors:  V Lucivero; M Prontera; D M Mezzapesa; M Petruzzellis; M Sancilio; A Tinelli; D Di Noia; M Ruggieri; F Federico
Journal:  Neurol Sci       Date:  2007-08-10       Impact factor: 3.307

10.  Cerebral Autoregulation in Hypertension and Ischemic Stroke: A Mini Review.

Authors:  Shashank Shekhar; Ruen Liu; Olivia K Travis; Richard J Roman; Fan Fan
Journal:  J Pharm Sci Exp Pharmacol       Date:  2017-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.